Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Mashup Score: 7

Journal of Clinical Oncology

Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION). -

VISION Trial showing benefit of Lu177-PSMA

Read the full article here
See more from Catherine Marshall